• Irish Exporters Association and Aer Lingus Cargo Partner to Support the Irish Pharmaceutical and Medical Devices Supply Chain

    The Irish Exporters Association (IEA) this morning (30th April) signed a partnership agreement with Aer Lingus Cargo which will support the exporting of pharmaceutical and medical devices across the transatlantic supply chain.

    The aim of the partnership between the IEA and Aer Lingus Cargo is to ensure the safe and timely distribution of temperature sensitive Life Sciences products and to maintain Ireland’s reputation as a global leader in pharmaceutical air-freight cargo exports.

    The IEA Life Sciences division of the Irish Exporters Association has been working closely with Aer Lingus Cargo on the handling and air-freight distribution of temperature sensitive pharmaceutical products. Over the past two years Aer Lingus Cargo has engaged with the IEA Good Distribution Practice (GDP) Programme and recently became the first airline to achieve the prestigious industry approved GDP Passport certification.

    In 2013, Ireland exported more than €21bn worth of Pharmaceuticals and Medical Devices and Aer Lingus Cargo is a key player in the supply chain that supports the exports of these products and devices.

    Michael Sanfey, Director of Cargo at Aer Lingus Cargo, commented:

    “Aer Lingus Cargo has made a significant investment in meeting the needs of its pharmaceutical customer base in recognition of the importance of the sector to Irish Exports and to the growth of Aer Lingus.  Our partnership with The Irish Exporters Association has been instrumental in allowing us to listen and learn from our customers. As we expand our services to 7-days a week to San Francisco and launch our new services to Washington DC this summer, we continue to thrive on serving the needs of the pharmaceutical industry in Ireland and North America.”

     Simon McKeever, Chief Executive of the Irish Exporters Association commented:

    “A key component of the pharmaceutical and medical devices supply chain is to ensure patient safety within the supply chain where airfreight is the preferred mode of transport for the export of temperature-controlled medicines. Aer Lingus Cargo’s investment in training and facilities puts them in a unique position to service transatlantic export pharmaceutical and medical devices. As Ireland continues to attract and retain leading Life Sciences companies, we look forward to partnering with the team in Aer Lingus Cargo.’’

    END

    For further information , please contact ;

    Gillian Ryan, Communications & Events Manager,

    Irish Exporters Association

    Tel: 01 642 4171           M: 087 299 3790

    Email: gillianryan@irishexporters.ie